Sally Wagner Partin

SALLY WAGNER PARTIN focuses her practice on representing leading technology and life sciences companies in the areas of mergers and acquisitions and related corporate advice. She guides both public and private companies through transformative events and critical governance matters, including acquisitions, sales, divestitures, and joint ventures. Her clients include companies across life sciences/biopharmaceutical and medical device/diagnostics, technology and fintech, consumer goods, and financial services.

Sally has been widely recognized by Chambers USA, Law360 as Life Sciences MVP of 2025, IFLR as a “Technology Lawyer of the Year,” The Daily Journal as one of the 100 “Top Women Lawyers” across all practices, and The Recorder as one of the 30 “Woman Leaders in Tech Law” for the California Legal Awards.

“Sally is an incredibly sophisticated, responsive, and thoughtful lawyer.”
Chambers USA 2025

Sally earned her J.D. from Harvard Law School, where she was the editor-in-chief of the Journal of Law and Gender, and her B.A. from Yale University.

Sally is a member of the Life Science Cares Bay Area board and an author of the Survey of Trends and Key Components of CVRs in Life Sciences Public M&A Deals.

Some notable transactions include representing the following:

HEALTHCARE & LIFE SCIENCES

• Roche in numerous public and private acquisitions, including Roche's acquisition of 89bio, Inc. (Nasdaq: ETNB), a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, for up to US$3.5 billion, including CVRs; Roche's acquisition of Carmot Therapeutics, a GLP-1 company developing obesity and diabetes treatment, for US$2.7 billion upfront and US$400 million in milestones; Roche's acquisition of Poseida Therapeutics (Nasdaq: PSTX), clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies, for up to US$1.5 billion, including CVRs, Roche in its acquisition of Ignyta, Inc. (Nasdaq: RXDX), a cancer therapy company for US$1.7 billion and in its acquisition of diagnostics company, GenMark (Nasdaq: GNMK) for US$1.8 billion, among others.
• Stryker in its acquisition of Inari Medical (Nasdaq: NARI), a medical device company specializing in venous thromboembolism devices, for US$4.9 billion.
• Genentech in its sale of one of the world's largest biologics manufacturing facilities to Lonza for US$1.2 billion.
• Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company focused on allergic and immunologic diseases, in its sale to BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) for US$700 million in cash and BioCryst stock.
• DaVita, a leading global healthcare company and one of the largest providers of kidney care services in the U.S., in various governance and securities matters. 
• Flatiron Health, a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients, in its inaugural M&A transaction to acquire Protocol First, a software solutions provider focused on accelerating clinical research.

 

TECH, CYBERSECURITY, AND FINTECH

• ServiceTitan (Nasdaq: TTAN), a leading software provider for the trades, in numerous acquisitions, including ServiceTitan's acquisition of FieldRoutes, a mobile SaaS provider for the lawn care and pest control industries; ServiceTitan's acquisition of Conduit Tech, an HVAC design and sales platform to enhance tools for HVAC contractors; ServiceTitan’s acquisition of Convex, a sales and marketing platform; and ServiceTitan’s acquisition of Schedule Engine, an online booking and live services customer service platform, among others.
• Palo Alto Networks, Inc. in numerous cybersecurity acquisitions, including its acquisition of security company, Demisto, for US$560 million in cash and stock, Bridgecew, Crypsis Group for US$256 million, CloudGenix Inc., for US$420 million, Aporeto for US$150 million, and Expanse for US$1.25 billion, among others.
• PayPal in numerous acquisitions, including its acquisition of Braintree and Venmo, mobile and web payment systems platforms and its acquisition of Xoom Corporation (Nasdaq: XOOM), a leading international digital money transfer provider for US$890 million in cash, and others.
• Markforged (NYSE: MKFG) a 3D printer company in its acquisition of Teton Simulation Software.
• Cadence Design Systems in its acquisition Rocketick Technologies Ltd, an Israeli-based hard technology company.
• Afilias, Inc., a registry operator of top-level domains and registry service provider, in connection with its sale for an undisclosed amount to Donuts Inc.
• Trustly, Europe’s leading online banking payments provider, in its acquisition of PayWithMyBank, an online banking payments company.
• Intuit in various acquisitions and divestitures, including its acquisition of Exactor, a leading cloud-based SaaS technology provider of sales and use tax calculation and filing, and in its acquihire of Xperiel, Inc., a unique digital experiential marketing platform.

 

RETAIL, CONSUMER, AND ONLINE MARKETPLACES

• ContextLogic (Nasdaq: WISH) in the sale of its Wish retail platform to Qoo10.
• ChargePoint, an electric vehicle charging platform, in various governance and securities matters. 
• eBay in numerous acquisitions, including its acquisition of shopping engine Milo and in the sale of its 18.4% holding in MercadoLibre, Inc., the largest online commerce platform in Latin America, for US$1.4 billion and its acquisition of SalesPredict, an Israeli-based analytics company, among others.
• Audio Up Inc., a podcast production studio and network, including in connection with various financing rounds to investors led by Metro-Goldwyn-Mayer Studios (MGM) Inc.
• Dolby Laboratories in its acquisition of SLS Audio, a speaker technology company.
• Centerview Partners LLP as financial advisor to the Independent Transaction Committee of the Board of Directors of Sprint Corporation in connection with the proposed combination of Sprint and T-Mobile US, Inc., in a stock-for-stock merger with a total implied enterprise value of approximately US$59 billion for Sprint and approximately US$146 billion for the combined company.